Recerca
Àrea 2
Aterosclerosi i malaltia coronària
Articles de l'any 2010
Original
Originals publicats: 33
Factor d'impacte: mitjana: 3.98, total: 131.29
-
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries
Widimsky P, Wijns W, Fajadet J, DeBelder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, DeServi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U
EUR HEART J. 2010; 31: 943-957. IF: 9.8 -
Characterization of Ion Channels Involved in the Proliferative Response of Femoral Artery Smooth Muscle Cells
Cidad P, Moreno-Dominguez A, Novensa L, Roque M, Barquin L, Heras M, Perez-Garcia MT, Lopez-Lopez JR
ARTERIOSCL THROM VAS. 2010; 30: 1203-0. IF: 7.235 -
Equine Estrogens Impair Nitric Oxide Production and Endothelial Nitric Oxide Synthase Transcription in Human Endothelial Cells Compared With the Natural 17 beta-Estradiol
Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP
HYPERTENSION. 2010; 56: 405-0. IF: 6.614 -
Cell cycle-dependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells
Miguel-Velado E, Perez-Carretero FD, Colinas O, Cidad P, Heras M, Lopez-Lopez JR, Perez-Garcia MT
CARDIOVASC RES . 2010; 86: 383-391. IF: 5.801 -
What lessons have been learnt from animal models of MRSA in the lung?
Martinez-Olondris P, Rigol M, Torres A
EUR RESPIR J. 2010; 35: 198-201. IF: 5.527
Revisió
Revisions publicades: 2
Factor d'impacte: mitjana: 4.2, total: 8.4
-
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
Bosch X, Marrugat J, Sanchis J
COCHRANE DB SYST REV. 2010; 0: 0-0. IF: 5.653 -
The Right Heart and Pulmonary Circulation. Is It Really a Minor Circulation?
Segovia J, Bermejo J, Alfonso F, Heras M
REV ESP CARDIOL. 2010; 63: 77-80. IF: 2.746
Editorials
Editorials publicades: 1
Factor d'impacte: mitjana: 6.91, total: 6.91
-
Safeguarding good scientific practice in Europe The increasingly global reach of science requires the harmonization of standards
Bosch X
EMBO REP. 2010; 11: 252-257. IF: 6.907
Multicèntrics
Multicèntrics publicats: 2
Factor d'impacte: mitjana: 30.93, total: 61.87
-
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KAA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S
NEW ENGL J MED. 2010; 363: 930-942. IF: 47.05 -
Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, Garcia-Garcia HM, VanEs GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW
CIRCULATION. 2010; 121: 1176-1187. IF: 14.816
Guies clíniques
Guies clínique publicades: 2
Factor d'impacte: mitjana: 6.1, total: 12.2
-
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Wijns W, Kolh P
EUR HEART J. 2010; 31: 2501-2555. IF: 9.8 -
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Kolh P, Wijns W, Danchin N, DiMario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Uva MS, Taggart D
EUR J CARDIO-THORAC. 2010; 38: 0-0. IF: 2.397
Patents
-
Use of voltage-gated potassium channel blocking substances in the manufacture of a pharmacological tool for the treatment of vascular diseases e.g. restenosis and post transplant chronic nephropathy
HOSPITAL CLINIC I PROVINCIAL BARCELONA; UNIV VALLADOLID